Christopher R. Garrett

7.1k total citations · 2 hit papers
50 papers, 5.3k citations indexed

About

Christopher R. Garrett is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Christopher R. Garrett has authored 50 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Christopher R. Garrett's work include Colorectal Cancer Treatments and Studies (21 papers), Gastrointestinal Tumor Research and Treatment (10 papers) and Gastric Cancer Management and Outcomes (9 papers). Christopher R. Garrett is often cited by papers focused on Colorectal Cancer Treatments and Studies (21 papers), Gastrointestinal Tumor Research and Treatment (10 papers) and Gastric Cancer Management and Outcomes (9 papers). Christopher R. Garrett collaborates with scholars based in United States, Canada and Germany. Christopher R. Garrett's co-authors include Martin E. Blackstein, Manisha H. Shah, Charles M. Baum, Paolo G. Casali, Jaap Verweij, George D. Demetri, Grant A. McArthur, Xin Huang, Ian Judson and Carlo L. Bello and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Christopher R. Garrett

49 papers receiving 5.1k citations

Hit Papers

Efficacy and safety of sunitinib in patients with advance... 2006 2026 2012 2019 2006 2007 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
    2006 1.9k citations George D. Demetri, Allan T. van Oosterom et al. The Lancet profile →
  2. Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab
    2007 898 citations Christopher R. Garrett et al. Journal of Clinical Oncology profile →

Peers

Christopher R. Garrett
J. Randolph Hecht United States
Jonathan Polikoff United States
Maria Di Bartolomeo Italy
Young Suk Park South Korea
Tomohiro Nishina Japan
Carlo L. Bello United States
Min‐Hee Ryu South Korea
Peter C. Enzinger United States
Bruno Landi France
Joan Maurel Spain
J. Randolph Hecht United States
Christopher R. Garrett
Citations per year, relative to Christopher R. Garrett Christopher R. Garrett (= 1×) peers J. Randolph Hecht

Countries citing papers authored by Christopher R. Garrett

Since Specialization
Citations

This map shows the geographic impact of Christopher R. Garrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Garrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Garrett more than expected).

Fields of papers citing papers by Christopher R. Garrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Garrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Garrett. The network helps show where Christopher R. Garrett may publish in the future.

Co-authorship network of co-authors of Christopher R. Garrett

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Garrett. A scholar is included among the top collaborators of Christopher R. Garrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Garrett. Christopher R. Garrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yihui, So‐Young Park, Jody V. Vykoukal, et al.. (2025). Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer Cells. Vaccines. 13(6). 629–629.
2.
Morelli, Maria Pia, Michael J. Overman, Arvind Dasari, et al.. (2015). Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment. Annals of Oncology. 26(4). 731–736. 186 indexed citations
3.
Pereira, Allan Andresson Lima, Van K. Morris, Michael J. Overman, et al.. (2014). Association between KRAS mutation and lung metastasis in advanced colorectal cancer. British Journal of Cancer. 112(3). 424–428. 71 indexed citations
4.
Morris, Van K., Michael J. Overman, Zhi-Qin Jiang, et al.. (2014). Progression-Free Survival Remains Poor Over Sequential Lines of Systemic Therapy in Patients With BRAF-Mutated Colorectal Cancer. Clinical Colorectal Cancer. 13(3). 164–171. 93 indexed citations
5.
Şahin, İbrahim Halil & Christopher R. Garrett. (2013). The heterogeneity of KRAS mutations in colorectal cancer and its biomarker implications: an ever-evolving story. 2(3). 164–166. 2 indexed citations
6.
Tanasanvimon, Suebpong, Naveen Garg, Chitra Viswanathan, et al.. (2013). High prevalence of recurrent thrombosis in subsets of cancer patients with isolated gonadal vein thrombosis: A single center retrospective study. Thrombosis Research. 133(2). 154–157. 9 indexed citations
7.
Şahin, İbrahim Halil, Manal M. Hassan, & Christopher R. Garrett. (2013). Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: Current state-of-the science. Cancer Letters. 345(2). 249–257. 43 indexed citations
8.
Das, Prajnan, Cathy Eng, Miguel A. Rodrı́guez-Bigas, et al.. (2013). Preoperative Radiation Therapy With Concurrent Capecitabine, Bevacizumab, and Erlotinib for Rectal Cancer: A Phase 1 Trial. International Journal of Radiation Oncology*Biology*Physics. 88(2). 301–305. 14 indexed citations
9.
10.
Garrett, Christopher R., Hesham M. Hassabo, Nishin A. Bhadkamkar, et al.. (2012). Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer. British Journal of Cancer. 106(8). 1374–1378. 124 indexed citations
11.
Brouquet, Antoine, Eddie K. Abdalla, Scott Kopetz, et al.. (2011). High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome. Journal of Clinical Oncology. 29(8). 1083–1090. 272 indexed citations
12.
Garrett, Christopher R. & Cathy Eng. (2011). Cetuximab in the treatment of patients with colorectal cancer. Expert Opinion on Biological Therapy. 11(7). 937–949. 42 indexed citations
13.
Brouquet, Antoine, Michael J. Overman, Scott Kopetz, et al.. (2011). Is resection of colorectal liver metastases after a second‐line chemotherapy regimen justified?. Cancer. 117(19). 4484–4492. 26 indexed citations
14.
Garrett, Christopher R., Domenico Coppola, Robert M. Wenham, et al.. (2010). Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT. Investigational New Drugs. 29(6). 1381–1389. 67 indexed citations
15.
16.
DePrimo, Samuel E., Xin Huang, Martin E. Blackstein, et al.. (2009). Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure. Clinical Cancer Research. 15(18). 5869–5877. 38 indexed citations
17.
Haque, Waqar, Christopher H. Crane, Sunil Krishnan, et al.. (2009). Reirradiation to the abdomen for gastrointestinal malignancies. Radiation Oncology. 4(1). 55–55. 16 indexed citations
18.
Javle, Milind, Jihnhee Yu, Christopher R. Garrett, et al.. (2009). Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study. British Journal of Cancer. 100(12). 1842–1845. 24 indexed citations
19.
Cangiano, José L., Barbara A. Centeno, Christopher R. Garrett, et al.. (2008). Signal Transduction Proteins in Tumors From Puerto Rican and Caucasian Gastric Adenocarcinoma Patients: Expression Differences With Potential for Specific Targeted Therapies. Digestive Diseases and Sciences. 53(8). 2090–2100. 5 indexed citations
20.
Demetri, George D., Allan T. van Oosterom, Christopher R. Garrett, et al.. (2006). Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. The Lancet. 368(9544). 1329–1338. 1930 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Randolph Hecht Breakdown of academic impact, for papers by Jonathan Polikoff Breakdown of academic impact, for papers by Maria Di Bartolomeo Breakdown of academic impact, for papers by Young Suk Park Breakdown of academic impact, for papers by Tomohiro Nishina Breakdown of academic impact, for papers by Carlo L. Bello Breakdown of academic impact, for papers by Min‐Hee Ryu Breakdown of academic impact, for papers by Peter C. Enzinger Breakdown of academic impact, for papers by Bruno Landi Breakdown of academic impact, for papers by Joan Maurel
Rankless by CCL
2026